Skip to main content
NCBI home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1997 Feb 15;25(4):917–918. doi: 10.1093/nar/25.4.917

Gene targeting in C57BL/6 ES cells. Successful germ line transmission using recipient BALB/c blastocysts developmentally matured in vitro.

F A Lemckert 1, J D Sedgwick 1, H Körner 1
PMCID: PMC146508  PMID: 9016649

Abstract

There are significant advantages to the production of gene-knockout mice directly in mouse strains other than 129. The availability now of ES cells derived from the C57BL/6 mouse strain presents workers with a valuable alternative. A major difficulty, however, is the requirement for BALB/c blastocysts as recipients for ES cell injection. Using standard procedures, few BALB/c blastocysts can be obtained. This limitation has now been resolved by harvesting BALB/c embryos at the early morula stage and maturing these to blastocysts by in vitro culture. Of early morulae harvested and cultured, over 70% were recovered as fully expanded and injectable blastocysts. C57BL/6 ES cell injection of these blastocysts has enabled the production of a number of gene-knockout mice with a success rate similar to that reported for ES cells derived from the 129 mouse strains.

Full Text

The Full Text of this article is available as a PDF (28.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Galli-Taliadoros L. A., Sedgwick J. D., Wood S. A., Körner H. Gene knock-out technology: a methodological overview for the interested novice. J Immunol Methods. 1995 Apr 12;181(1):1–15. doi: 10.1016/0022-1759(95)00017-5. [DOI] [PubMed] [Google Scholar]
  2. Gerlai R. Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurosci. 1996 May;19(5):177–181. doi: 10.1016/s0166-2236(96)20020-7. [DOI] [PubMed] [Google Scholar]
  3. Kopf M., Brombacher F., Köhler G., Kienzle G., Widmann K. H., Lefrang K., Humborg C., Ledermann B., Solbach W. IL-4-deficient Balb/c mice resist infection with Leishmania major. J Exp Med. 1996 Sep 1;184(3):1127–1136. doi: 10.1084/jem.184.3.1127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Köntgen F., Süss G., Stewart C., Steinmetz M., Bluethmann H. Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int Immunol. 1993 Aug;5(8):957–964. doi: 10.1093/intimm/5.8.957. [DOI] [PubMed] [Google Scholar]
  5. Ledermann B., Bürki K. Establishment of a germ-line competent C57BL/6 embryonic stem cell line. Exp Cell Res. 1991 Dec;197(2):254–258. doi: 10.1016/0014-4827(91)90430-3. [DOI] [PubMed] [Google Scholar]
  6. Marx J. Leishmania susceptibility puzzle gets another twist. Science. 1996 Feb 16;271(5251):912–913. doi: 10.1126/science.271.5251.912. [DOI] [PubMed] [Google Scholar]
  7. Stewart C. L. Production of chimeras between embryonic stem cells and embryos. Methods Enzymol. 1993;225:823–855. doi: 10.1016/0076-6879(93)25053-5. [DOI] [PubMed] [Google Scholar]
  8. Stewart C. L., Schuetze S., Vanek M., Wagner E. F. Expression of retroviral vectors in transgenic mice obtained by embryo infection. EMBO J. 1987 Feb;6(2):383–388. doi: 10.1002/j.1460-2075.1987.tb04766.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Wood S. A., Allen N. D., Rossant J., Auerbach A., Nagy A. Non-injection methods for the production of embryonic stem cell-embryo chimaeras. Nature. 1993 Sep 2;365(6441):87–89. doi: 10.1038/365087a0. [DOI] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES